CURRICULUM VITAE Gerald Louis Andriole, Jr., M.D. Address ...

Grant Title:
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to
Investigate the Long Term Effects of Finasteride (MK-906) in Patients with
Benign Prostatic Hyperplasia
Funding Agency:
Merck, Sharp & Dohme
Period: 1992 – 1994
Grant Title:
A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Examine
Changes in Prostate Morphology Following Six Months of Therapy with
Finasteride in Men with Mildly Elevated PSA Levels and Benign Prostate
Hyperplasia with One year extension Study
Funding Agency:
Janssen Pharmaceuticals
Period: 1992 - 1997
Grant Title:
A Randomized, Open Label Study to Determine the Effect of R85,246 on PSA
Levels in Subjects with Relapsed or Progressive Prostate Cancer
Funding Agency:
Schering Laboratories
Period: 1994-1996
Grant Title:
Finasteride Plus Flutamide Study
Funding Agency:
Miles
Period: 1995
Grant Title:
Therapy of Non-Bacterial Prostatitis
Funding Agency:
Merck, Sharp & Dohme
Period: 1995
Grant Title:
Prospective Randomized Trial of the Effect of Finasteride in Free PSA
Funding Agency:
C.R. Bard, Inc.
Period: 1995-1996
Grant Title:
Antegrade Collagen Injection: A New Technique for Post Prostatectomy Stress
Incontinence
Funding Agency:
Applied Immune Sciences, Inc.
Period: 1995
Grant Title:
Multi-Center Randomized Phase II/III Trial of CD8(+) Tumor Infiltrating
Lymphocyte Cell Therapy and Recombinant Interleukin-2 (rIL-2) in Metastatic
Renal Cell Cancer
Funding Agency:
Janssen
Period: 1997
Grant Title:
Phase II Double-Blind Study to Determine the Tolerability & Efficacy of Three
Different Doses of Liarazole in Patients with Rising PSA Levels After Definitive
Treatment (LIA-INT26)
Funding Agency:
Janssen
Period: 1997
Grant Title:
A Phase II Open Randomized Multicenter Study to Determine the Safety and
Efficacy of Liarazole with Prednisone in Patients with Relapsed Androgen
Independent D-3 Prostate Cancer
7